Agios pharmaceuticals inc

Major-Pharmaceuticals

AGIO


88 Sidney Street
Cambridge , MA 02139

Executive/
Director

Price

  • Last Close
  • $ 61.61
    $ +2.63 4.46 %
    Dec 6, 2024
  • 52-Week High/Low
  • $48.85 - $19.97
  • YTD
  • 176.7%

  • Trading Volume
  • 44,757
  • Market Cap Full
  • $ 3.4B
  • Shares Outstanding
  • 55.9M
    Oct 27, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 -15.8% -37.5% 40% 43.1% 46.3% -5% 19.2% -11.4% -18.2% 31.3%
Q2 17.9% 3.2% -11.9% 14.4% -21.7% 4% 6.7% -23.8% 23.3% -0.7%
Q3 -36.5% 26.1% 29.7% -9.8% -31% 8% -14.7% 27.6% -12.6% -
Q4 -8% -21% -16.2% -39.8% 40% 23.8% -30.1% -0.7% -8.1% -
J F M A M J J A S O N D
2024 1.6% 42.9% -9.5% -2% - - - - - - - -
2023 5% -14.2% -9.3% -0.4% 10.5% 12% -6.4% 3.4% -9.8% -15.1% 5.8% 0.2%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    368%-42%-36%37%-19%5%-10%-24%-15%-21%177%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.13 0.61 1.56 -1.63 -1.59 -0.59 26.95 -1.74 -1.47
Q2 0.85 1.47 1.78 -1.19 -1.87 -1.31 -1.41 -1.68 -1.51
Q3 1.07 1.63 1.59 -1.63 -1.81 -1.43 -1.56 -1.49 -1.64
Q4 1.08 1.34 1.81 -1.58 -1.59 -1.41 2.57 0.68 -
A 3.1 5.1 6.7 -6 -6.9 -4.7 26.6 -4.2 -4.62

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 58.4 68.5 69.6 54.6 55.3
Jun 57.6 58.7 68.9 61.6 54.8 55.6
Sep 58 58.8 69.1 59 54.8 55.7
Dec 58.2 58.9 69.3 54.3 54.9 55.9

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 0.3 - 0.2 0.1 1
Fixed Asset Turnover - - 1.6 0.6 0.4
Total Asset Turnover - - 0.2 0.1 0.1
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 2.5 0.2 -28.7 28.4 22.6
Equity multiplier 0.3 0.2 0.3 0.3 0.4